The Lubrizol Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3719
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

The Lubrizol Corporation – Strategy, SWOT and Corporate Finance Report
Summary

The Lubrizol Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

The Lubrizol Corporation (Lubrizol or ‘the company’), a wholly-owned subsidiary of Berkshire Hathaway, manufactures, distributes, and markets lubricant additives and performance chemicals used in consumer and industrial applications. The company offers driveline systems, heavy duty diesel engines, industrial applications, motorcycle engine oils, power tool engine oils and recreational equipment engine oils. Lubrizol also provides chlorinated polyvinyl chloride (cpvc) piping systems and materials, engineered polymers, life science polymer products and personal and home care products under brands such as Corzan, More Inside, LUCANT, Zer0, Carbopol, Estane, TempRite, BlisterBond and Carbocur. The company operates through a network of manufacturing facilities, laboratories, sales offices and technical offices in countries across North America, Europe and Asia-Pacific. Lubrizol is headquartered in Wickliffe, Ohio, the US.

Scope

- Detailed information on The Lubrizol Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting The Lubrizol Corporation in the form of a SWOT analysis
- An in-depth view of the business model of The Lubrizol Corporation including a breakdown and examination of key business segments
- Intelligence on The Lubrizol Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about The Lubrizol Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of The Lubrizol Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess The Lubrizol Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on The Lubrizol Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
The Lubrizol Corporation: Company Overview 9
The Lubrizol Corporation: Overview and Key Facts 9
The Lubrizol Corporation: Overview 9
The Lubrizol Corporation: Key Facts 9
The Lubrizol Corporation: Key Employees 10
The Lubrizol Corporation: Key Employee Biographies 12
The Lubrizol Corporation: Major Products and Services 17
The Lubrizol Corporation: Company History 19
The Lubrizol Corporation: Management Statement 22
The Lubrizol Corporation: Key Competitors 25
The Lubrizol Corporation: Company Analysis 26
The Lubrizol Corporation: Business Description 26
The Lubrizol Corporation: SWOT Analysis 28
The Lubrizol Corporation: SWOT Overview 28
The Lubrizol Corporation: Strengths 28
The Lubrizol Corporation: Weaknesses 29
The Lubrizol Corporation: Opportunities 29
The Lubrizol Corporation: Threats 30
The Lubrizol Corporation: Corporate Financial Deals Activity 32
The Lubrizol Corporation: Financial Deals Overview 32
The Lubrizol Corporation: Targets and Partners 34
The Lubrizol Corporation: Top Deals 2014 – 2018YTD* 35
The Lubrizol Corporation: Advisors 36
The Lubrizol Corporation: Top Legal Advisors 36
The Lubrizol Corporation: Mergers and Acquisitions 37
The Lubrizol Corporation: Corporate Venturing 38
The Lubrizol Corporation: Partnership 39
The Lubrizol Corporation: Recent Developments 40
The Lubrizol Corporation: News and Events Summary 40
The Lubrizol Corporation: Business Expansion 43
The Lubrizol Corporation: Corporate Governance 44
The Lubrizol Corporation: Market Developments 44
Appendix 48
Contact Us 48
Methodology 48
About MarketLine 49

List of Tables
Table 1: The Lubrizol Corporation: Key Facts
Table 2: The Lubrizol Corporation: Key Employees
Table 3: The Lubrizol Corporation: Key Competitors
Table 4: The Lubrizol Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 5: The Lubrizol Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: The Lubrizol Corporation: M&A Average Deal Size - Value (US$m)
Table 7: The Lubrizol Corporation: Targets and Partners
Table 8: The Lubrizol Corporation: Top Deals 2014 - 2018YTD*
Table 9: The Lubrizol Corporation: Legal Advisor Ranking by Value (US$m)
Table 10: The Lubrizol Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: The Lubrizol Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 12: The Lubrizol Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 13: The Lubrizol Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: The Lubrizol Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: The Lubrizol Corporation: News and Events Summary
Table 16: The Lubrizol Corporation: Business Expansion
Table 17: The Lubrizol Corporation: Corporate Governance
Table 18: The Lubrizol Corporation: Market Developments

List of Figures
Figure 1: The Lubrizol Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: The Lubrizol Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: The Lubrizol Corporation: M&A Average Deal Size - Value (US$m)
Figure 4: The Lubrizol Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: The Lubrizol Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: The Lubrizol Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: The Lubrizol Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: The Lubrizol Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[The Lubrizol Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Binggrae Co., Ltd.:企業の戦略・SWOT・財務情報
    Binggrae Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Binggrae Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pentax Europe GmbH-医療機器分野:企業M&A・提携分析
    Summary Pentax Europe GmbH (Pentax Medical), a subsidiary of Hoya Corp is a medical device company that provides clinical endo-imaging solutions. The company offers products in the therapeutic areas of gastroenterology, endoscopic ultrasound, ENT and speech, pulmonology, and urology. Its products in …
  • MTU Aero Engines Holdings AG (MTX):企業の財務・戦略的SWOT分析
    MTU Aero Engines Holdings AG (MTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Galapagos NV (GLPG):製薬・医療:M&Aディール及び事業提携情報
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines. The company’s clinical pipeline include filgotinib, which is in Phase III clinical trials for the treatment of rheumatoid arthritis and Crohn’s disease, Phase 2 and 3 trials for ulcerati …
  • Peak Resources Ltd. (PEK):企業の財務・戦略的SWOT分析
    Peak Resources Ltd. (PEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hanger, Inc. (HNGR)
    Hanger, Inc. (HNGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Hayashibara Co Ltd:企業の戦略的SWOT分析
    Hayashibara Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Bacardi Ltd:企業の戦略的SWOT分析
    Bacardi Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Evgen Pharma Plc (EVG):製薬・医療:M&Aディール及び事業提携情報
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a clinical-stage drug development company that develops clinical pipeline for breast cancer and subarachnoid haemorrhage. The company develops SFX-01 to reduce the vasospasm and incidence of delayed cerebral ischemia which leads t …
  • Novartis Institutes for BioMedical Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Novartis Institutes for BioMedical Research Inc (NIBR), a subsidiary of Novartis AG is a medical research institute that offers treatment research and development programs. The institute offers clinical research services in areas of immuno-oncology, oncology, neuroscience, cardiovascular and …
  • Shelby Energy Cooperative, Inc.:企業の戦略的SWOT分析
    Shelby Energy Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Streamline Health Solutions Inc (STRM):医療機器:M&Aディール及び事業提携情報
    Summary Streamline Health Solutions Inc (Streamline Health) is a medical technology company that offers patient engagement and SaaS-based solutions. The company provides solutions including HIM, patient engagement, patient care, coding and CDI, and financial management solutions. It offers its patie …
  • PACCAR Inc.:戦略・SWOT・企業財務分析
    PACCAR Inc. - Strategy, SWOT and Corporate Finance Report Summary PACCAR Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • The InterTech Group Inc:企業の戦略的SWOT分析
    The InterTech Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Pharco Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharco Pharmaceuticals Inc (Pharco Pharmaceuticals), a subsidiary of Pharco Corp, is a manufacturer of branded and generic pharmaceutical products. The company offers products such as alambupine, alfatral, amlodipine, amrase, amrizole, bisadyl, bromhexine, carbolase, ciprofloxacin, dexametha …
  • CSL Limited:企業のM&A・事業提携・投資動向
    CSL Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CSL Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Dunelm Group plc (DNLM):企業の財務・戦略的SWOT分析
    Dunelm Group plc (DNLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Cutera Inc (CUTR):企業の財務・戦略的SWOT分析
    Cutera Inc (CUTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析
    Summary InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing mi …
  • HCA Healthcare, Inc.:戦略・SWOT・企業財務分析
    HCA Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary HCA Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆